PARKER H STEWART - 27 Apr 2021 Form 4/A - Amendment Insider Report for IMPEL NEUROPHARMA INC

Role: Director
Signature: /s/ John Leaman, M.D. as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 27 Apr 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 22 Jun 2021, 17:47:45 UTC
Date Of Original Report: 29 Apr 2021
Previous filing: 22 Jun 2021
Next filing: 13 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMPL	Common Stock						20,151	27 Apr 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the amount of securities beneficially owned by the reporting person following all transactions reported in Table I on the Form 4 filed on April 29, 2021.

Remarks:

The Form 4 filed on April 29, 2021 inadvertently reported the net exercise of Class A-2 preferred stock warrants and Class C-1 preferred stock warrants. The referenced warrants were cash exercised and therefore this amended Form 4 removes the effect of the withholding transactions as reported on the Form 4 by correcting the number of derivative securities beneficially owned by the reporting person following all reported transactions on Table I.